Fundraising Fox

OCV Partners

Venture capital

Los Angeles · Pre-Seed–Late Stage · 5 people tracked

Also known as OCV MANAGEMENT, LLC

Find your way into OCV Partners

1,162 people in our graph share verified history with the OCV Partners team — schools, employers, funds. One of them is your warm intro.

Mike Zakunlockedknows Chris Bostick · together at Cornell (overlapped)
knows the team · via Cornell
knows the team · via UCLA Anderson School of Management
×5knows the team · via Morgan Stanley
knows the team · via Nomura
knows the team · via Milkeninstitute
Fox Verdict
Sign up to see your fit

Investment thesis

OCV Partners invests in brilliant teams building disruptive technology, drawing on the partners' background as former founders who have grown businesses from early stages through IPOs. Its core focus areas are Technology (SaaS, FinTech, and PropTech), with expertise in subscription and recurring-revenue software models, and Healthcare (Healthcare SaaS, Digital Health, MedTech, and BioTech). In healthcare, the firm backs companies enabling precision and targeted approaches, empowering better treatment decisions, removing barriers to equitable care, and expediting discovery of new treatments. OCV aims to create asymmetric advantages for founders and offers flexible capital, preferring but not requiring to lead rounds.

Source: firm website, verified Sep 15, 2026.

Stage
Pre-Seed–Late Stage
HQ
Los Angeles, CA, US
Leads rounds
Leads
Instruments
Equity
Founded
2022
Last 12 months
1 investment
Private fund assets
$172.9M
VC funds
1
Tracked investments
25
IPOs
2
Acquisitions
1

Team · 5 people

from the firm's website & public directories
Joe Sassi· Senior Associatein

What they invest in

from 20 of 25 portfolio companies

Healthtech ×8AI & Machine Learning ×7Biotech ×6Consumer ×3Creator Economy ×3Deep Tech ×3Enterprise Software ×3Fintech ×3

HQs:United States×16Mexico×1

Who they back

founder profiles across 12 portfolio companies
50%
solo founders
6 of 12 mapped founding teams
56%
repeat founders
of 16 founders with career history

Founding team size:solo founder×62 founders×34+ founders×3

Where their founders studiedfrom 14 founders with education data

Technion ×2The Johns Hopkins University School of Medicine ×2UCLA ×2University of Pennsylvania ×2

What their founders studiedfrom 14 founders with field-of-study data

Life Sciences ×4Business & Management ×3Computer Science ×2Economics ×2Engineering ×2Humanities ×2Physics ×2

Investments · 25 tracked

founders shown can be your intro path

By year:2026 · 12025 · 12024 · 32022 · 22021 · 32018 · 111 dated

Praxispraxismedicines.comin𝕏NASDAQ: PRAX

Praxis Precision Medicines is a central nervous system precision neuroscience biopharmaceutical company developing therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance, with a pipeline spanning movement disorders and epilepsy.

BiotechDeep TechHealthtechBoston, US

Steve Petrou(Co-Founder, President of Research & Development)inKiran Reddy(Executive Officer, Director)inMarcio Souza(President & Chief Executive Officer)in

BoardNicholas G. Galakatos(Director)

Co-investorsAvoro Capital AdvisorsCapria VenturesAlameda ResearchAPOLLO PROJECTSBlackstoneClarus+6 more

Precision BioSciencesprecisionbiosciences.comin𝕏NASDAQ: DTIL

Precision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

BiotechDeep TechHealthtechDurham, US

DEREK JANTZ(Executive Officer, Director)inMATTHEW KANE(Executive Officer, Director)Jeff Smith(Co-founder)inDerek Jantz(Co-founder)inTODD MELBY(Executive Officer)inMichael Amoroso(President, Chief Executive Officer)in

Co-investorsage1Agent CapitalAliment CapitalBrace PharmaF-Prime CapitalOUP (Osage University Partners)+4 more

SafeBreach Attack Simulation Platformsafebreach.comin𝕏✓ verified

SafeBreach offers a continuous threat exposure management (CTEM) platform that combines breach and attack simulation, attack path validation, and an AI agent to help enterprise security teams identify, prioritize, and remediate cyber risk.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaS

Guy Bejerano(CEO & Co-founder)inItzik Kotler(CTO & Co-founder)inMichal Weiner(Chief Financial Officer)inRaman Kumar(Chief Customer Officer)in

Co-investorsBain CapitalDTCP33NBright Pixel CapitalDnx VenturesEmerald Development Managers+2 more

ByHeartbyheart.cominJul 2021

ByHeart is an infant formula company that manufactures science-driven baby formula with its own manufacturing process and supply chain.

ConsumerDirect to ConsumerFoodTechHealthtechNew York, US

Mia B. Funt(Executive Officer, Director)inRon Belldegrun(Co-founder)inMia Funt(Founder)inMia(Co-founder)Georg Krause-Vilmar(Executive Officer)inNiall Mullane(Executive Officer)in

Board seatHemi Zucker· per SEC Form D

Co-investorsEvolution VC PartnersPolaris PartnersRed Sea VenturesVida Ventures

Figure 8museumoficecream.comin

Museum of Ice Cream operates interactive, ice cream-themed attractions featuring immersive rooms, a sprinkle pool, novelty desserts, cocktails, and retail products.

ConsumerMedia & Entertainment

Manish V.(Founder)in

Co-investorsElizabeth Street VenturesMaywic Select Investments

Figure8figure-8.coin

Figure 8 is an experience-first company that designs and operates immersive venues known as "experiums," including the Museum of Ice Cream and Home Quart brands.

ConsumerCreator EconomyMedia & EntertainmentMexico City, MX

Maryellis Bunn(Founder & CEO)Manish Vora(Co-founder)

Finch Therapeuticsfinchtherapeutics.comin𝕏Feb 2018

Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.

BiotechHealthtechMedical DevicesSomerville, US

Mark Smith(Executive Officer, Director)inMatt Blischak(Chief Executive Officer)inR. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)

Co-investorsB3 HoldingOctave Ventures LlcOMX VenturesShumway CapitalHumboldt

Invoice2go2go.com

Subscription-based mobile app helping small business owners win jobs, track payments, and manage client payment options.

Co-investorsAccelRibbit Capital

Ockam fintech-blockchainockam.io

Ockam is an open-source library that enables developers to build secure communication channels with end-to-end encryption and mutual authentication across any network, cloud, or on-premises infrastructure.

CybersecurityDeveloper ToolsSan Francisco, US

Matthew Gregory(Founder)in

Co-investorsAspect VenturesCore Ventures GroupSGH CapitalSINEWAVE VENTURESFuture Ventures

Olapicolapic.comin𝕏Acquired

Social Native (at olapic.com) offers an AI-powered creator marketing platform trained on 1.8M+ creator collaborations and $8B in paid media, predicting brief, creator, and platform performance before spend.

AI & Machine LearningCreator EconomyE-commerceMarketing TechSocialNew York, US

David Shadpour(Founder & CEO)inEytan Elbaz(Co-Founder)inJose De Cabo(Executive Officer, Director)Luis Sanz Arilla(Executive Officer, Director)

BoardBen Lin(Director)

Co-investorsAct One VenturesContour Venture PartnersFELIX CAPITALScout VenturesScout VenturesLongworth Venture Partners+2 more

Orcaorca.fyiin𝕏Apr 2021 · $13M

Orca offers a mobile banking platform targeting young adults, featuring peer-to-peer money transfers, group bill-splitting, local merchant discounts, and integrated spending and savings tools.

FintechSan Francisco, US

DY ​(Founder)inTim Qin(Founder)in

Co-investorsY CombinatorMizMaa VenturesMusha Ventures

Orcaorca.soin𝕏Apr 2021 · $13M

Orca is a liquidity protocol and trading platform on the Solana blockchain that enables users to discover, deploy, and manage yield strategies across decentralized liquidity pools.

Crypto & Web3Fintech

Michael Hwang(CEO)in

Co-investors6th Man VenturesCollab+CurrencyMarin Digital VenturesPlaceholder VCRockawayXRyze Labs+4 more

Orcaorcawater.lifeinMay 2024 · $23M

Orca Water builds a water monitoring and predictive leak detection system that uses ultrasonic sensors and machine learning to visualize and localize water use down to specific fixtures via an interactive dashboard.

AI & Machine LearningCleantechIoT

Co-investorsForesightInnovation UBCAnkona CapitalBrighton Park CapitalEnza CapitalMizMaa Ventures+2 more

Orcaorcainc.comin𝕏May 2024 · $23M

Orca is a software platform that modernizes venture capital fund management by automating operations and streamlining workflows.

Enterprise SoftwareFintechSaaS

Shalom(CEO and Founder)Itzik(Head of Growth)Artem(Chief Product Officer)Meital(CFO)

Co-investorsF2 Venture CapitalState of Mind VenturesAnkona CapitalBrighton Park CapitalEnza CapitalMizMaa Ventures+2 more

Orca AIorca-ai.ioinMay 2025 · $72.5M

Orca AI applies computer vision and deep learning to maritime shipping, providing situational awareness and automation tools to help commercial vessels navigate more safely and operate more efficiently.

AI & Machine LearningDeep TechLogistics & Supply ChainMobility & Transportation

Yarden Gross(Co-founder & CEO)inDor Raviv(Co-founder & CTO)inShoval Bolotin(VP Product / Operations)inFabrizio Ferraro(Global Sales Lead)inLirit(CFO)inAmit(VP R&D)in

Co-investorsAnkona CapitalBrighton Park CapitalMizMaa VenturestheDOCKSanta Barbara Venture Partners

OSSIOossio.ioin𝕏

OSSIO develops OSSIOfiber, a bio-integrative bone fixation implant material made from natural mineral fibers that provides stability during healing and integrates fully into bone over 18-24 months, avoiding permanent metal hardware.

BiotechHealthtechMedical DevicesNew MaterialsPalmetto, US

Orahn Preiss-Bloom(Founder & Chief Innovation Officer)inBrian Verrier(Chief Executive Officer)inBrennan Marilla(Chief Commercial and Operating Officer)inMoshe Shneor(Chief Financial Officer)inGregory C. Berlet(Chief Medical Officer)

Co-investorsQuesta CapitalSecocha Ventures

Ozetteozette.comin𝕏Jul 2022

Ozette runs a vertically integrated, AI-enabled lab and platform that generates high-dimensional spectral cytometry data and analyzes it to produce reproducible biomarker endpoints for clinical trials.

AI & Machine LearningBiotechHealthtech

Greg Finak(Founder)inEvan Greene(Co-founder)inAli Ansary(Co-founder)in

Co-investorsAllen Institute for AI (AI2) IncubatorAlpha Ascent Ventures LlcM12 (Microsoft's Venture Fund)AlexandriaMadrona Venture Group

Rad AIradai.comin𝕏

Rad AI develops generative AI models and automation solutions specifically designed for radiology and healthcare workflows.

AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSan Francisco, US

Dr. Jeff Chang(Co-founder)inDoktor Gurson(Co-founder)in

BoardStuart Peterson(Director)inBruce Armstrong(Director)in

PartnerChris Bostick· led

Co-investorsAlpha PartnersArray Ventures Management LlcArtis VenturesCity LightCorewell Health VenturesFifty Years+9 more

Social Nativesocialnative.aiin𝕏

Social Native runs an AI-powered creator marketing platform that matches brands with content creators, predicts campaign performance, and manages briefs-to-payout, drawing on data from 1.8M+ creator collaborations and $8B in paid media.

AI & Machine LearningCreator EconomyMarketing TechSaaSBeverly Hills, US

David Shadpour(Founder)in

BoardJordan Levy(Director)

Co-investorsBow CapitalFELIX CAPITALMiramar Venture PartnersScout VenturesTenOneTen Ventures

TechStyle Fashion Grouptechstylefashiongroup.com

Online subscription fashion retailer carrying shoes, handbags, jewelry, and denim through brands including Fabletics, Justfab, ShoeDazzle, and Savage x Fenty.

Laura Jones Joukovskiin

Co-investorsCrosscut VenturesManhattan WestL CattertonNeuberger BermanSugar Capital

Torl Biotorlbio.comApr 2024

TORL BioTherapeutics is a clinical-stage biopharmaceutical company developing antibody-drug conjugates and monoclonal antibodies for cancer, including lead candidate TORL-1-23 targeting CLDN6 in ovarian cancer.

BiotechCulver City, US

Mark Alles(Executive Officer, Director)Mark Attanasio(Director)David Licata(Executive Officer, Director)Neil O'Brien(Director)Amit Sinha(Director)Lynn Seely(Director)

PartnerChris Bostick· led

Co-investorsRA CapitalCowen Healthcare InvestmentsGoldman SachsPerceptive Xontogeny VentureVertex Ventures HC

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

MeridianMade, Inc.1200 PharmaLexenseOzette Technologies, Inc.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 3

2 IPOs · 1 acquisitions · showing 2

PraxisNASDAQ: PRAXPrecision BioSciencesNASDAQ: DTIL

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has OCV Partners made?
OCV Partners has 25 tracked investments, 3 of which have exited, including 2 dated in the last 24 months.
What stage does OCV Partners invest at?
OCV Partners invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does OCV Partners focus on?
OCV Partners focuses on AI & Machine Learning, Biotech, Digital Health, Enterprise Software, Fintech, Healthtech, Medical Devices, PropTech, SaaS.
Where is OCV Partners located?
OCV Partners is headquartered in Los Angeles, US.
Does OCV Partners lead rounds?
Yes, OCV Partners leads investment rounds.
Who does OCV Partners co-invest with?
OCV Partners most often shares deals with FELIX CAPITAL, Scout Ventures, Aspect Ventures, among 58 tracked co-investors.

From the blog

visit blog ↗

Recent posts cover portfolio company developments in healthcare and maritime AI, including Rad AI's radiology generative AI products, its $60M Series C raise and RSNA Ventures partnership, and Orca AI's $72.5M raise for autonomous ship navigation. AI summary

Media · Podcasts & interviews

featuring the team

Chris Bostick, OCV Partners

socaltech · Chris Bostick

Images

OCV Partners photo

Similar investors

Featured in lists